Cronos Group Inc.

TSX:CRON.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$4.57 -0.27%

-$0.01 today

Market cap
$1.67B
Beta
1.25
P/E (TTM)
-488.1
EPS (TTM)
-$0.01
52W Low $2.54High $4.66

Volume 0.15M

Average 0.19M

CRON.TO Investing Cash Flow

Net cash used in or generated by investments in assets, acquisitions, and securities.

Cronos Group Inc.TSX: CRON.TO

Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Investing cash flow turns positive

Q1 FY2026 investing cash flow was $37.41M, compared with -$55.36M a year earlier. Trailing-twelve-month investing cash flow was $16.31M. Over 3 fiscal years it compounded at +248.4% a year.

Context

  • Investing cash flow amounted to 52.2% of revenue in FY2025, down 96.8 pp from a year earlier.
  • Investing cash flow increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly investing cash flow holds near $37.41M or moves back toward the trailing-twelve-month quarterly average of $4.08M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$37.41M+1195.3% QoQ
Last fiscal yearDec 2025
-$77.9M-144.5% YoY
LTMMar 2026
$16.31M+123.4% YoY
Investing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+167.6%——
1 year-144.5%——
3-year CAGR+248.4%——
5-year CAGR——
10-year CAGR——

Investing Cash Flow history

USD · from the cash flow

Latest · FY2025
(77.9M) USD
Year-over-year change
-144.5%

Investing Cash Flow vs competitors

How CRON.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so investing cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +123.4% is the 2nd highest of 6, against a peer median of -5.0%.
  • Investing cash flow amounts to 10.2% of revenue for CRON.TO, versus a peer median of 19.8%.
CRON.TO Competitors
Investing Cash Flow for CRON.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
EXE.TOExtendicare Inc.LTM Jun 2026CA$601.86M CAD+469.6%—30.4%
SIA.TOSienna Senior Living Inc.LTM Sep 2026CA$378.15M CAD+6.8%+52.8%34.0%
GUD.TOKnight Therapeutics Inc.LTM Mar 2026CA$101.01M CAD-241.7%+10.1%19.8%
WELL.TOWELL Health Technologies Corp.LTM Mar 2026CA$98.29M CAD-5.0%+43.4%6.7%
CRON.TOCronos Group Inc.LTM Mar 2026$16.31M USD+123.4%+248.4%10.2%
TLRY.TOTilray Brands, Inc.LTM Feb 2026$13.84M USD-8.8%+29.5%1.6%
Peer median (excluding CRON.TO) —-5.0%+36.4%19.8%

Competitors are the stored peer set for CRON.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(397.2M)(168.73M)(74.55M)40.02M(9.61M)
Depreciation & Amortization15.4M13.12M8.11M9.34M14.48M
Deferred Income Tax222.22M043.32M00
Stock-Based Compensation10.15M15.12M8.77M8.7M0
Change in Working Capital(2.01M)20.66M(26.47M)(311K)(35.02M)
Accounts Receivables(13.16M)(2.71M)9.21M(2.51M)(26.2M)
Inventory11.57M(7.22M)7.4M7.42M(10.58M)
Accounts Payables(2.37M)(863K)(773K)(7.45M)1.13M
Other Working Capital1.97M31.45M(42.3M)2.24M636.96K
Other Non-Cash Items(2.18M)30.89M(2.01M)(38.9M)56.47M
Operating Cash Flow(153.62M)(88.95M)(42.84M)18.84M26.32M
Capital Expenditures(12.26M)(5.03M)(3.42M)(13.15M)(26.17M)
Acquisitions (Net)(1.12M)0724K5.99M2.9M
Purchases of Investments(230M)(271.38M)(608.25M)0(59.44M)
Sales of Investments215.3M268.87M532.84M185.82M5.15M
Other Investing Activities(819K)5.7M18.61M(4.25M)0
Investing Cash Flow(28.9M)(1.84M)(59.5M)175.15M(77.9M)
Debt Repayment00000
Common Stock Issued15.73K0000
Common Stock Repurchased0(2.85M)(1.03M)0(9.91M)
Dividends Paid00000
Other Financing Activities(13.46M)(42.36K)(2.47K)(1.23M)(10.34M)
Financing Cash Flow(13.44M)(2.9M)(1.03M)(1.23M)(20.25M)
Effect of Forex Changes4.91M(28.64M)8.01M(3.25M)(37.24M)
Net Change in Cash(191.05M)(122.33M)(95.35M)189.51M(109.07M)
Free Cash Flow(165.88M)(93.98M)(46.26M)5.69M151.61K

Cronos Group Inc.

TSX:CRON.TO

Intrinsic Alpha fair value

Locked

Current Price

$4.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.